Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Continuous Flow Reactor Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111039829A enables safe continuous production of p-acetamido benzene sulfonyl chloride, offering high purity and supply chain stability for global buyers.
Patent CN114369041B enables efficient continuous flow synthesis. Reduces costs and improves supply chain reliability for antibiotic intermediates.
Patent CN113121424A details a micro-reactor process for Palbociclib intermediates, offering superior purity, safety, and scalable manufacturing capabilities.
Patent CN111039829B details a safe continuous flow method for producing p-acetamidobenzenesulfonyl chloride, offering high purity and reduced waste for pharmaceutical intermediates.
Patent CN115417895A reveals a safer microchannel hydrogenation process for cis-propenyl phosphoric acid, offering >97% selectivity and reduced catalyst costs for fosfomycin production.
Patent CN110845337B reveals a safer microreactor bromination route for kinase inhibitor intermediates, offering superior selectivity and scalable manufacturing solutions.
Patent CN112358499A details a safer, continuous synthesis of glufosinate-ammonium, eliminating toxic ethylene oxide and reducing solvent waste for cost-effective herbicide manufacturing.
Discover the advanced continuous flow synthesis of (3aS,6aR)-lactone per patent CN114560865A. Achieve >99% ee and >90% yield with reduced costs and enhanced supply reliability for biotin production.
Patent CN113845417A details a safer continuous flow method for naproxen intermediates. Discover cost reduction and high-purity manufacturing advantages.
Patent CN111848517B details a novel continuous flow method for Edaravone. Achieve high purity >99% and safer manufacturing. Contact us for supply.
Patent CN115286532A reveals a continuous micro-reactor method for synthesizing DL-aminopropionitrile, offering high purity and scalable manufacturing for methyldopa intermediates.
Patent CN103588662A details a novel continuous-flow method for synthesizing Betamipron, offering enhanced purity and reduced toxicity for reliable pharmaceutical intermediate supply chains.
Patent CN103588662A details a continuous-flow microreactor method for synthesizing Betamipron, offering superior purity and cost reduction in API manufacturing compared to conventional batch processes.
Patent CN111072515B reveals a green continuous flow method for cephalosporin intermediates, offering significant cost reduction and supply chain stability for global pharma manufacturers.